Frontiers SARS-CoV-2 Spike Protein Expression In Vitro and

Severe COVID-19 can be associated with a prothrombotic state, increasing risk of morbidity and mortality. The SARS-CoV-2 spike glycoprotein is purported to d

Frontiers SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development

Frontiers SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation

Frontiers Nucleic Acid-Based Treatments Against COVID-19

Frontiers SARS-CoV-2 and the Host Cell: A Tale of Interactions

SARS‐CoV‐2 spike protein enhances MAP4K3/GLK‐induced ACE2 stability in COVID‐19

Frontiers Neuropathological Aspects of SARS-CoV-2 Infection: Significance for Both Alzheimer's and Parkinson's Disease

Frontiers Microglial Implications in SARS-CoV-2 Infection and COVID-19: Lessons From Viral RNA Neurotropism and Possible Relevance to Parkinson's Disease

Frontiers Structural Characterization of SARS-CoV-2: Where We

Mechanisms of SARS-CoV-2 entry into cells

Microorganisms, Free Full-Text

Frontiers A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection

Frontiers Experimental Models of COVID-19

Frontiers Optimization of SARS-CoV-2 Spike Protein Expression in